Medicare Enrolled

Dr. Chelsea Beiser, P.A.

Medical Physician Assistant · Katy, TX
Low-engagement
25230 KINGSLAND BLVD STE 102, Katy, TX 77494
2818693009
In practice since 2016 (9 years)
NPI: 1497297394 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beiser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beiser? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beiser

Dr. Chelsea Beiser is a medical physician assistant in Katy, TX, with 9 years in practice.

Between the years covered by Open Payments, Dr. Beiser received a total of $14,470 from 37 pharmaceutical and/or device companies across 718 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beiser is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice$ $14,470 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$14,470
Total received (2021-2024)
Avg $3,617/year across 4 years
Top 2% in TX for medical physician assistant
37
Companies
718
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,475 (93.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$995 (6.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,086
2023
$3,892
2022
$3,262
2021
$3,230

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,434
Regeneron Healthcare Solutions, Inc.
$1,363
Takeda Pharmaceuticals U.S.A., Inc.
$1,334
Janssen Biotech, Inc.
$1,268
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,209
QOL Medical, LLC
$717
Celgene Corporation
$682
AbbVie Inc.
$582
PFIZER INC.
$501
Ardelyx, Inc.
$354
Braintree Laboratories, Inc.
$350
Nestle HealthCare Nutrition Inc.
$342
RedHill Biopharma Inc.
$336
Janssen Scientific Affairs, LLC
$327
Madrigal Pharmaceuticals
$323
Ironwood Pharmaceuticals, Inc
$288
Lilly USA, LLC
$242
VIVUS LLC
$230
E.R. Squibb & Sons, L.L.C.
$228
GENZYME CORPORATION
$176
Celltrion USA Inc.
$160
Merck Sharp & Dohme LLC
$135
Ferring Pharmaceuticals Inc.
$126
Gilead Sciences, Inc.
$122
IRONWOOD PHARMACEUTICALS, INC
$117
Pharmacosmos Therapeutics Inc.
$95
AIMMUNE THERAPEUTICS, INC.
$91
Phathom Pharmaceuticals, Inc.
$75
Exact Sciences Corporation
$58
Lucid Diagnostics Inc.
$43
NESTLE HEALTHCARE NUTRITION INC.
$38
EVOKE PHARMA, INC.
$36
Merck Sharp & Dohme Corporation
$22
INTERCEPT PHARMACEUTICALS, INC.
$19
Alnylam Pharmaceuticals Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Ethicon US, LLC
$14
Top 3 companies account for 35.5% of total payments
Associated products mentioned in payments ›
Aemcolo · CIMZIA · CLENPIQ · CREON · CYLTEZO · Cologuard Collection Kit · DIFICID · DUPIXENT · ENTYVIO · GATTEX · GIMOTI · HUMIRA · IBSRELA · INFLECTRA · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · Movantik · OCALIVA · OMVOH · ONPATTRO · PANCREAZE · QSYMIA · Qsymia · REBYOTA · REMICADE · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for medical physician assistant in TX.

Looking for a medical physician assistant in Katy?
Compare medical physician assistants in the Katy area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical Physician Assistants within 10 mi
288
Per 100K population
33.5
County median income
$113,409
Nearest hospital
MEMORIAL HERMANN KATY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Beiser is a medical physician assistant, and high industry engagement (low-engagement, top 2%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Beiser receive payments from pharmaceutical companies?
Yes. Dr. Beiser received a total of $14,470 from 37 companies across 718 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Beiser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →